Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONS
2. ASML
3. BSX
4. ODFL
5. USO
6. LAD
7. SPIR
8. ROIV
9. ORCL
10. CRCL

Go back to Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
(NASDAQ: RXRX) Delayed: 3.64 +0.01 (0.28%)
Previous Close $3.63    52 Week High $ 
Open $3.64    52 Week Low $ 
Day High $3.64    P/E N/A 
Day Low $3.64    EPS $ 
Volume 274,764       

(NASDAQ: RXRX) Delayed: 3.64 +0.01 (0.28%)
Previous Close $3.63    52 Week High $ 
Open $3.64    52 Week Low $ 
Day High $3.64    P/E N/A 
Day Low $3.64    EPS $ 
Volume 274,764